Safety and Immunogenicity Study of Multiclade HIV-1 Adeno-Viral Vector Vaccine Alone or as Boost Following a Multiclade HIV-1 DNA Vaccine in Africa. PLoS ONE, 5, e12873. presented at the 09/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20877623. (2010).
Safety and Efficacy of a Calcineurin-Inhibitor Avoidance Regimen in Pediatric Renal Transplantation. J Am Soc Nephrol, 17, 1735-1745. presented at the 06/2006. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16687625. (2006).
Phase 1 Safety and Immunogenicity Evaluation of ADVAX a Multigenic, DNA-Based Clade C/B’ HIV-1 Candidate Vaccine. PLoS ONE, 5, e8617. presented at the 01/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20111582. (2010).
Phase 1 Safety and Immunogenicity Evaluation of ADMVA, a Multigenic, Modified Vaccinia Ankara-HIV-1 Clade B'/C Candidate Vaccine. PLOS One, 5, e8816. presented at the 01/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20111599. (2010).
North American Pediatric Renal Transplant Cooperative Study. Outcome of renal transplantation in adolescents with focal segmental glomerulosclerosis. Pediatr Transplantation, 6, 488-92. presented at the 2002.. (2002).
Incidence of PTLD in Pediatric Renal Transplant Recipients Receiving Basiliximab, Calcineurin Inhibitor, Sirolimus and Steroids. Am J Transplant, 8, 984-989. presented at the 05/2008. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18416737. (2008).
Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids. Am J Transplant, 8(5), 984-9. presented at the 2008 May. doi:10.1111/j.1600-6143.2008.02167.x. (2008).
Safety and Immunogenicity of VRC Multiclade HIV-1 Adenoviral Vector Vaccine Alone or with VRC Multiclade HIV-1 DNA Plasmid Vaccine in the African Adults. In AIDS Vaccine 2007 Conference. presented at the 20/08/2007, Seattle, WA. Retrieved from http://www.vaccineenterprise.org/conference_archive/2007/index.html. (2007).
The Effect of Cataract Surgery on the Development of Geographic Atrophy. In Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO). presented at the 06/05/2007, Fort Lauderdale, FL.. (2007).
Cellular and Humoral Immunogenicity of ADMVA, a Clade C/B MVA-Based HIV-1 Candidate Vaccine, in Healthy Volunteers. In AIDS Vaccine 2007 Conference. presented at the 20/08/2007, Seattle, WA. Retrieved from http://www.vaccineenterprise.org/conference_archive/2007/index.html. (2007).